ABSTRACT
COVID-19 has caused radical effects on the daily lives of millions of people. The causal agent of the current pandemic is SARS-CoV-2, a virus that causes symptoms related to the respiratory system, leading to severe complications. In the in vitro fertilization (IVF) universe, there are several protocols for infection control and laboratory safety. Some professional associations have issued guidelines recommending measures involving patient flow and IVF practices. This study presents a review and considerations for the resumption of activities in IVF laboratories and clinics in Brazil during the COVID-19 pandemic, according to the guidelines and statements from professional organizations and societies in reproductive medicine.
Subject(s)
Ambulatory Care Facilities/organization & administration , COVID-19 , Fertilization in Vitro , Infection Control , Adolescent , Adult , Aged , Aged, 80 and over , Brazil , COVID-19/epidemiology , COVID-19/prevention & control , Child , Child, Preschool , Fertilization in Vitro/legislation & jurisprudence , Fertilization in Vitro/methods , Fertilization in Vitro/standards , Humans , Infant , Infection Control/legislation & jurisprudence , Infection Control/methods , Infection Control/standards , Laboratories/legislation & jurisprudence , Laboratories/standards , Middle Aged , Pandemics , SARS-CoV-2 , Young AdultABSTRACT
SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effective antiviral therapies have been identified so far. The current outbreak is challenging governments and health authorities all over the world. In here we present a comparison among the current diagnostic tools and kits being used to test Brazilian population.